title: Shortcomings in pharmacy benefit forecasting--interferon beta products.
authors: Sheldon J
authors: SJ
authors: Rich
authors: Christina
authors: C
authors: Meyer
mesh_terms: D000276:Adjuvants, Immunologic / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000191:economics / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*
chemical_list: D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a